Javascript must be enabled to continue!
Deletion mapping of chromosome 19 in human gliomas
View through CrossRef
AbstractThere is evidence that a putative glioma tumor suppressor locus resides on the long arm of chromosome 19. We present data on 161 gliomas from IS6 patients, which were studied by microsatellite analysis for loss of heterozygosity (LOH) on chromosome 19. Eight loci on the long arm and 2 loci on the short arm of chromosome IV were examined. LOH on I9qwas observed in 3/19 astrocytomas (WHO grade II), 12/27 anaplastic astrocytomas (WHO grade III), 16/76 cases of glioblastoma multiforme WHO (grade IV), 4/9 oligodendrogliomas (WHO grade II), 3/5 anaplastic oligodendrogliomas (WHO grade III), 5/9 mixed oligo‐astrocytomas (WHO grade II) and 8/10 anaplastic oligo‐astrocytomas (WHO grade III). While 31 of the tumors with LOH on chromosomal arm I9q exhibited allelic loss at every informative locus, 20 tumors showed terminal or interstitial deletions. In contrast to astrocytomas and glioblastomas, tumors with an oligodendroglial component had predominantly lost the entire long arm of chromosome 19. The common region of overlap in gliomas was located on 19q 13.2‐q 13.4 between the markers D 19S 178 and D 19S 180. Our data confirm the involvement of a putative tumor suppressor gene on chromosomal arm 19q in gliomas and assign this gene to 19q 13.2‐q 13.4.
Title: Deletion mapping of chromosome 19 in human gliomas
Description:
AbstractThere is evidence that a putative glioma tumor suppressor locus resides on the long arm of chromosome 19.
We present data on 161 gliomas from IS6 patients, which were studied by microsatellite analysis for loss of heterozygosity (LOH) on chromosome 19.
Eight loci on the long arm and 2 loci on the short arm of chromosome IV were examined.
LOH on I9qwas observed in 3/19 astrocytomas (WHO grade II), 12/27 anaplastic astrocytomas (WHO grade III), 16/76 cases of glioblastoma multiforme WHO (grade IV), 4/9 oligodendrogliomas (WHO grade II), 3/5 anaplastic oligodendrogliomas (WHO grade III), 5/9 mixed oligo‐astrocytomas (WHO grade II) and 8/10 anaplastic oligo‐astrocytomas (WHO grade III).
While 31 of the tumors with LOH on chromosomal arm I9q exhibited allelic loss at every informative locus, 20 tumors showed terminal or interstitial deletions.
In contrast to astrocytomas and glioblastomas, tumors with an oligodendroglial component had predominantly lost the entire long arm of chromosome 19.
The common region of overlap in gliomas was located on 19q 13.
2‐q 13.
4 between the markers D 19S 178 and D 19S 180.
Our data confirm the involvement of a putative tumor suppressor gene on chromosomal arm 19q in gliomas and assign this gene to 19q 13.
2‐q 13.
4.
Related Results
The prognostic significance of XL DLEU/LAMP (13q14 deletion) in CCL patients: a cross section study
The prognostic significance of XL DLEU/LAMP (13q14 deletion) in CCL patients: a cross section study
Background: Many cytogenetic abnormalities were detected in CLL, one of them. Deletion of 13q14 region which is found in more than 50% of CLL patient. 13q deletion is the most comm...
Decreased Expression of PACSIN1 in Brain Glioma Samples Predicts Poor Prognosis
Decreased Expression of PACSIN1 in Brain Glioma Samples Predicts Poor Prognosis
Gliomas are the most severe brain tumours with a poor prognosis. Although surgery, postoperative radiotherapy and chemotherapy can improve the survival rate of glioma patients, the...
Molecular classification of adult gliomas: recent advances and future perspectives
Molecular classification of adult gliomas: recent advances and future perspectives
Purpose of review
This review summarizes recent advances in the molecular classification of adult gliomas.
Recent findings
...
The allelic loss of chromosome 3p25 with c‐myc gain is related to the development of clear‐cell renal cell carcinoma
The allelic loss of chromosome 3p25 with c‐myc gain is related to the development of clear‐cell renal cell carcinoma
To explore the role of allelic losses at 3p25 and genetic alterations of chromosome 8, we investigated the relationships between genetic alterations in these chromosomal regions an...
The genotype and phenotype of chromosome 18p deletion syndrome
The genotype and phenotype of chromosome 18p deletion syndrome
Abstract
Rationale:
The chromosome 18p deletion syndrome is a syndrome with a deletion of all or a portion of the short arm of the chromosome 18....
Abstract 1345: Mutant IDH1 and tissue factor in gliomas
Abstract 1345: Mutant IDH1 and tissue factor in gliomas
Abstract
Background: IDH1 mutations (IDH1mut) occur in 20-30% of gliomas, induce DNA hypermethylation, and are associated with a better prognosis than IDH1 wild-type...
BIOM-17. DIFFERENCES IN THE IMMUNE MICROENVIRONMENT OF GLIOMAS HARBORING IDH2 VERSUS IDH1 MUTATIONS
BIOM-17. DIFFERENCES IN THE IMMUNE MICROENVIRONMENT OF GLIOMAS HARBORING IDH2 VERSUS IDH1 MUTATIONS
Abstract
INTRODUCTION
IDH mutations are a defining feature of lower-grade glioma and secondary glioblastoma. Approximately 95% o...
SURG-05. EXPERIENCE PROFILING OF FLUORESCENCE-GUIDED SURGERY FOR GLIOMAS
SURG-05. EXPERIENCE PROFILING OF FLUORESCENCE-GUIDED SURGERY FOR GLIOMAS
Abstract
Numerous studies reported a usefulness of 5-ALA fluorescence-guided surgery (FGS) in high grade gliomas. However, fluorescence pattern and intensity is vari...

